Staphylococcus aureus mutants lacking cell wall-bound protein A found in isolates from bacteraemia, MRSA infection

Marit Sørum1, Maria Sangvik, Marc Stegger

  • 1Staphylococcus Laboratory, Statens Serum Institut, Copenhagen, Denmark.

Pathogens and Disease
|April 27, 2013
PubMed

Insights

Frameshift mutations in Staphylococcus aureus cause truncated Staphylococcal protein A (SpA), leading to its extracellular presence. These truncated SpA variants are found in infections and carriers, impacting pathogenesis.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Immunology

Background:

  • Staphylococcus aureus is a significant human pathogen.
  • Staphylococcal protein A (SpA) is a key virulence factor involved in immune evasion and inflammation.
  • The function of SpA is linked to its cell wall anchoring via a C-terminal sorting signal.

Purpose of the Study:

  • To investigate if frameshift mutations in the spa repeat region of S. aureus lead to truncated SpA secretion.
  • To determine the localization of truncated SpA in clinical isolates.

Main Methods:

  • Sequencing of full-length spa genes from seven S. aureus isolates.
  • Western blot analysis to detect and localize SpA.
  • Analysis of frameshift mutations and their effect on SpA structure.

Main Results:

  • Frameshift mutations in all seven isolates resulted in premature stop codons, producing truncated SpA lacking the C-terminal sorting signal.
  • Truncated SpA was detected extracellularly in six of the seven isolates.
  • Isolates included those from blood cultures, MRSA infections, and nasal carriers.

Conclusions:

  • S. aureus can secrete truncated SpA lacking cell wall anchoring.
  • Truncated SpA is present in clinical settings, including bacteremia and carrier states.
  • This finding has implications for understanding S. aureus pathogenesis and immune interaction.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Archaeal Cell Wall01:29

Archaeal Cell Wall

Archaeal cell walls are structurally and compositionally distinct from their bacterial counterparts, lacking the characteristic peptidoglycan layer found in most bacteria. Instead, archaeal cell walls exhibit remarkable diversity, utilizing materials such as pseudomurein, polysaccharides, and proteins to construct their protective outer layers. This structural flexibility is closely tied to archaea's ecological adaptability.S-Layers: The Common Archaeal Cell WallThe S-layer is the most...
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Inhibitors of Gram-positive Cell Wall Synthesis01:23

Inhibitors of Gram-positive Cell Wall Synthesis

Bacterial cell walls are typically rigid structures composed mainly of peptidoglycan, a mesh-like polymer that provides mechanical strength and maintains cell shape. The synthesis of peptidoglycan is a crucial process in bacterial growth and serves as a primary target for many antibiotics.Mechanism of Action of Beta-Lactam AntibioticsBeta-lactam antibiotics, such as penicillin, inhibit peptidoglycan synthesis in actively growing cells. These antibiotics share a characteristic four-membered...